Combined use of heparin and anisodamine reduces the risk of early thrombosis in native arteriovenous fistula

Vascular

Volumn 21, Issue 6, 2013, Pages 369-374

  Chen, Lan ^a   Ling, Yi Sheng ^a   Lin, Chun Hua ^a   Guan, Tian Jun ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

anisodamine; arteriovenous fistula; chronic kidney disease; heparin; thrombosis

Indexed keywords

ANISODAMINE; CREATININE; HEPARIN;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD FLOW VELOCITY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; GLOMERULUS FILTRATION; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RISK REDUCTION; THROMBOSIS; VASOSPASM; VERY ELDERLY; ARTERIOVENOUS SHUNT;

ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT, SURGICAL; HEPARIN; HUMANS; RENAL DIALYSIS; THROMBOSIS;

EID: 84898916630     PISSN: 17085381     EISSN: 1708539X     Source Type: Journal    
DOI: 10.1177/1708538113478756     Document Type: Article

References (15)

1. Ashley I,Gursharan D,Trevor Met al.Preventing AV FISTULAS thrombosis: the rationale and design of the omega-3 fatty acids (Fish Oils) and aspirin in vascular access outcomes in renal disease (FAVOURED) study.BMC Nephrol. 2009;10:1.
2. Allon M,Robbin ML.Increasing arteriovenous fistulas in hemodialysis patients: problems and solution.Kidney Int. 2002;62:1109-24.
3. Polkinghorne KR,McDonald SP,Atkins RCet al.Vascular access and all-cause mortality: a propensity score analysis.J Am Soc Nephrol. 2004;15:477-86.
4. Pastan S,Soucie JM,McClellan WM.Vascular access and increased risk of death among hemodialysis patients.Kidney Int. 2002;62:620-6.
5. Asif A,Roy-Chaudhury P,Beathard GA.Early arteriovenous fistula failure: a logical proposal for when and how to intervene.Clin J Am Soc Nephrol. 2006;1:332-9.
6. Sidawy AN,Gray R,Besarab Aet al.Recommended standards for reports dealing with arteriovenous hemodialysis accesses.J Vasc Surg. 2002;35:603-10.
7. Andrassy K,Malluche H,Bornefeld H.Prevention of p.o. clotting spective double bling study.Klin Wochenschr. 1974;52:348-9.
8. Kooistra MP,Van Es A,Marx JJMet al.Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin.Nephrol Dial Transplant. 1994;9:1115-20.
9. Grontoft KC,Larsson R,Mulec Het al.Effects of ticlopidine in AV-fistula surgery in uremia.Scand J Urol Nephrol. 1998;32:276-83.
10. Dember LM,Beck GJ,Allon Met al.Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis.JAMA. 2008;299:2164-71.
11. Dixon BS,Beck GJ,Vazquez MAet al.Effect of dipyridamole plus aspirin on hemodialysis graft patency.N Engl J Med. 2009;360:2191-201.
12. Dixon BS,Beck GJ,Dember LMet al.Use of aspirin associates with longer primary patency of hemodialysis grafts.J Am Soc Nephrol. 2011;22:773-81.
13. Wang BR,Rowe VL,Ham SVVet al.A prospective clinical evaluation of the effects of intraoperative systemic anticoagulation in patients undergoing arteriovenous fistula surgery.Am Surg. 2010;10:1112-4.
14. Ives CL,Akoh JA,George Jet al.Pre-operative vessel mapping and early post-operative surveillance duplex scanning of arteriovenous fistulae.J Vasc Access. 2009;10:37-42.
15. Tong Y,Jinq Y,Qu Z.Heparins, effect of Chinese herbal fomentation on arteriovenous fistula maturation.J Altern Complement Med. 2011;6:261-78.